4//SEC Filing
Frantz John R 4
Accession 0001209191-20-056080
CIK 0000708818other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 4:20 PM ET
Size
12.5 KB
Accession
0001209191-20-056080
Insider Transaction Report
Form 4
Frantz John R
CEO and President
Transactions
- Award
Common Stock
2020-10-27+111,429→ 566,359 total - Award
Performance Stock Units
2020-10-27+167,143→ 388,302 total→ Common Stock (167,143 underlying)
Footnotes (2)
- [F1]The shares of restricted stock vest over three years from the date of grant in annual increments (i.e., 1/3 vest on the first anniversary of the date of grant, 1/3 vest on the second anniversary of the date of grant, and 1/3 vest on the third anniversary of the date of grant), subject to continued service through each vesting date.
- [F2]The performance stock unit awards vest only in the event certain performance goals are achieved and there is continuous service through the date the goals are certified. Approximately 80% of the performance stock units are tied to the Company's fiscal year 2022 revenue goal and 20% are tied to the Company's fiscal year 2023 revenue goal. Performance stock unit awards funded for fiscal year 2022 and fiscal year 2023 revenue performance will be modified for cumulative 3-year total shareholder return ("TSR") on the three-year grant date anniversary, which is also the cliff vest date. The number of shares to be issued may vary between 8.5% and 199.5% of the number of target performance stock units depending on performance, and no such shares will be issued if threshold performance is not achieved.
Issuer
NEXTGEN HEALTHCARE, INC.
CIK 0000708818
Entity typeother
Related Parties
1- filerCIK 0001645338
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 4:20 PM ET
- Size
- 12.5 KB